Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Herstellerkennzeichnung
Die Herstellerinformationen sind derzeit nicht verfügbar.
Inhaltsangabe
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.- Myocardial Perfusion.- Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.- Local and neurohumoral control of coronary blood flow.- ACE-inhibitors in coronary artery disease?.- Myocardial Hypertrophy.- Molecular mechanisms of cardiac gene expression.- Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.- ACE-inhibitors and coronary microcirculation.- Ventricular Remodelling.- Myocardial fibrosis: role of angiotensin II and aldosterone.- Ventricular remodeling after myocardial infarction. Experimental and clinical studies.- Infarct Size, Reperfusion, Restenosis.- "Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction?.- Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.- Angiotensin-converting enzyme inhibitor in a human model of restenosis.- Heart failure.- Pathophysiology of heart failure and the renin-angiotensin-system.- Angiotensin-converting enzyme inhibitors in the treatment of clinical heart failure.- Summary and Perspectives.- A. Basic aspects.- B. Clinical aspects.
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.- Myocardial Perfusion.- Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.- Local and neurohumoral control of coronary blood flow.- ACE-inhibitors in coronary artery disease?.- Myocardial Hypertrophy.- Molecular mechanisms of cardiac gene expression.- Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.- ACE-inhibitors and coronary microcirculation.- Ventricular Remodelling.- Myocardial fibrosis: role of angiotensin II and aldosterone.- Ventricular remodeling after myocardial infarction. Experimental and clinical studies.- Infarct Size, Reperfusion, Restenosis.- "Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction?.- Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.- Angiotensin-converting enzyme inhibitor in a human model of restenosis.- Heart failure.- Pathophysiology of heart failure and the renin-angiotensin-system.- Angiotensin-converting enzyme inhibitors in the treatment of clinical heart failure.- Summary and Perspectives.- A. Basic aspects.- B. Clinical aspects.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
